[General toxic and organotropic properties of azlocillin in acute and chronic experiments].
The general toxic and organotropic properties of azlocillin were studied in acute and chronic experiments with various animal species. By the body surface area the doses of azlocillin were equivalent to the drug average and maximum course doses for humans. The aim of the study was to determine the drug dose inducing certain side effects. It was found that only in a dose equivalent to the maximum course dose for humans i. e. 300 g the drug induced a transient increase in the blood levels of aspartate aminotransferase and alkaline phosphatase and some increase in the coagulation time. The allergenic properties of the drug were slightly pronounced. Within the tested doses azlocillin did not affect the peripheral blood indices and showed no immunomodulating embryotoxic, teratogenic or mutagenic effect. The experimental data indicated that the range between the drug therapeutic course doses and the doses inducing certain side effects was significant. This is evidence of a sufficiently high level of azlocillin safety.
D000276:Adjuvants, Immunologic; D000818:Animals; D001390:Azlocillin / Q000633:toxicity*; D001769:Blood / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004622:Embryo, Mammalian / Q000187:drug effects; D007668:Kidney / Q000187:drug effects; D007928:Lethal Dose 50; D008099:Liver / Q000187:drug effects; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D009153:Mutagens; D010525:Peripheral Nerves / Q000187:drug effects; D051381:Rats; D012119:Respiration / Q000187:drug effects; D013997:Time Factors
D000276:Adjuvants, Immunologic; D009153:Mutagens; D001390:Azlocillin
Izuchenie obshchetoksicheskikh i organotropnykh svoĭstv azlotsillina v ostrom i khronicheskom éksperimente.